Europe Nicotine Gum Market Size, Share & Trends Analysis Report By Type (2 mg and 4 mg), By Distribution Channel (Pharmacies, Supermarkets & Hypermarkets, and Online Stores. By Country and Growth Forecast, 2024 - 2031

The Europe Nicotine Gum Market is projected to witness market growth of 5.0% CAGR during the forecast period (2024-2031). In the year 2021, the Europe market's volume surged to 9.38 million units (100pcs. Per pack), showcasing a growth of 14.0% (2020-2023).

Pharmacies are a key distribution channel in the nicotine gum market, offering a trusted source for smoking cessation products. Pharmacists provide professional advice and guidance on the appropriate use of nicotine gum, ensuring consumers choose the right strength and dosage for their needs. Pharmacies often carry a wide range of nicotine gum options, including various flavors and dosages, to accommodate different preferences and requirements. Thus, the Germany market registered a volume of 1.37 million units in 2023.



The Germany market dominated the Europe Nicotine Gum Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $136.9 million by 2031. The UK market is exhibiting a CAGR of 4.2% during (2024 - 2031). Additionally, The France market is projected to experience a CAGR of 5.9% during (2024 - 2031).

Nicotine gum helps people stop smoking, but it's also used in harm reduction tactics for those who want to cut back on their tobacco use but aren't ready or willing to give up smoking entirely. By substituting cigarettes with nicotine gum, smokers can reduce their exposure to harmful chemicals and lower their overall health risks associated with smoking, such as cardiovascular disease, respiratory issues, and certain cancers.

The adoption and usage trends of nicotine gum reflect its evolving role as a prominent smoking cessation aid and nicotine replacement therapy (NRT) option. Various factors, including public health initiatives, consumer preferences, healthcare policies, and advancements in product formulations, influence these trends. Over the years, there has been a significant increase in public awareness about the health risks associated with smoking.

High smoking rates have driven demand for smoking cessation products, including nicotine gum, as more individuals seek to quit smoking. This demand has fueled market growth and product innovation. According to the Eurostat (2023), in 2019, 18.4 % of people aged 15 years and over in the EU were daily smokers. Among the EU Member States, the share of daily smokers ranged from 6.4 % in Sweden and 9.9 % in Finland to 23.6 % in Greece and 28.7 % in Bulgaria. European governments have implemented various anti-smoking campaigns and policies to reduce smoking rates. These initiatives have promoted the use of nicotine replacement therapies (NRT), including nicotine gum, further boosting the market. Thus, high rates of mortality due to tobacco is driving the growth of the market.

List of Key Companies Profiled

• Johnson & Johnson
• Novartis AG
• ITC Limited
• Cipla Limited
• Perrigo Company PLC
• Philip Morris International, Inc.
• ALCHEM INTERNATIONAL PVT. LTD.
• Alkalon A/S

Market Report Segmentation

By Type (Volume, thousand units (100pcs. Per pack), USD Billion, 2020-2031)

• 2 mg
• 4 mg

By Distribution Channel (Volume, thousand units (100pcs. Per pack), USD Billion, 2020-2031)

• Pharmacies
• Supermarkets & Hypermarkets
• Online Stores

By Country (Volume, thousand units (100pcs. Per pack), USD Billion, 2020-2031)

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe